Perspective on fibrinolytic therapy in COVID-19: the potential of inhalation therapy against suppressed-fibrinolytic-type DIC
作者： Hidesaku Asakura , Haruhiko Ogawa
DOI: 10.1186/S40560-020-00491-Y
关键词:
摘要: A high rate of thrombotic complications, such as pulmonary embolism, has been linked to mortality in COVID-19, and appropriate treatment thrombosis is important for lifesaving. Although heparin frequently used treat pathology embolism still seen severe cases. systemic fibrinolytic therapy a focus attention because the cause death it should be kept mind that might harmful at advanced stage COVID-19 where status disseminated intravascular coagulation (DIC) transmitted from suppressed-fibrinolytic enhanced-fibrinolytic disease progression COVID-19. In this respect, inhalation with substances safe promising treatment.
biomedcentral.com
sci-hub.st 参考文章(20)
Werner Zenz, Bettina Zoehrer, Michael Levin, Sergio Fanconi, Tassos D Hatzis, Geoff Knight, Marcus Müllner, Saul N Faust, International Paediatric Meningococcal Thrombolysis Study Group, Use of recombinant tissue plasminogen activator in children with meningococcal purpura fulminans: A retrospective study* Critical Care Medicine. ,vol. 32, pp. 1777- 1780 ,(2004) , 10.1097/01.CCM.0000133667.86429.5D
Hidesaku Asakura, Classifying types of disseminated intravascular coagulation: clinical and animal models Journal of intensive care. ,vol. 2, pp. 20- 20 ,(2014) , 10.1186/2052-0492-2-20
Kathleen A Stringer, Meghan Tobias, John S Dunn, Jackie Campos, Zachary Van Rheen, Mitra Mosharraf, Rajiv Nayar, Accelerated dosing frequency of a pulmonary formulation of tissue plasminogen activator is well-tolerated in mice. Clinical and Experimental Pharmacology and Physiology. ,vol. 35, pp. 1454- 1460 ,(2008) , 10.1111/J.1440-1681.2008.05011.X
Elisabetta Mantuano, Pardis Azmoon, Coralie Brifault, Michael A. Banki, Andrew S. Gilder, Wendy M. Campana, Steven L. Gonias, Tissue-type plasminogen activator regulates macrophage activation and innate immunity. Blood. ,vol. 130, pp. 1364- 1374 ,(2017) , 10.1182/BLOOD-2017-04-780205
Cristina Zalfa, Pardis Azmoon, Elisabetta Mantuano, Steven L. Gonias, Tissue-type plasminogen activator neutralizes LPS but not protease-activated receptor-mediated inflammatory responses to plasmin. Journal of Leukocyte Biology. ,vol. 105, pp. 729- 740 ,(2019) , 10.1002/JLB.3A0818-329RRR
Ahmed Abdelaal Ahmed Mahmoud, Hatem Elmoutaz Mahmoud, Mohamed Ali Mahran, Marwa Khaled, Streptokinase Versus Unfractionated Heparin Nebulization in Patients With Severe Acute Respiratory Distress Syndrome (ARDS): A Randomized Controlled Trial With Observational Controls. Journal of Cardiothoracic and Vascular Anesthesia. ,vol. 34, pp. 436- 443 ,(2020) , 10.1053/J.JVCA.2019.05.035
Xiaobo Yang, Yuan Yu, Jiqian Xu, Huaqing Shu, Jia'an Xia, Hong Liu, Yongran Wu, Lu Zhang, Zhui Yu, Minghao Fang, Ting Yu, Yaxin Wang, Shangwen Pan, Xiaojing Zou, Shiying Yuan, You Shang, Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory Medicine. ,vol. 8, pp. 475- 481 ,(2020) , 10.1016/S2213-2600(20)30079-5
Ning Tang, Dengju Li, Xiong Wang, Ziyong Sun, Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. Journal of Thrombosis and Haemostasis. ,vol. 18, pp. 844- 847 ,(2020) , 10.1111/JTH.14768
Fei Zhou, Ting Yu, Ronghui Du, Guohui Fan, Ying Liu, Zhibo Liu, Jie Xiang, Yeming Wang, Bin Song, Xiaoying Gu, Lulu Guan, Yuan Wei, Hui Li, Xudong Wu, Jiuyang Xu, Shengjin Tu, Yi Zhang, Hua Chen, Bin Cao, Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. ,vol. 395, pp. 1054- 1062 ,(2020) , 10.1016/S0140-6736(20)30566-3
Janice Wang, Negin Hajizadeh, Ernest E. Moore, Robert C. McIntyre, Peter K. Moore, Livia A. Veress, Michael B. Yaffe, Hunter B. Moore, Christopher D. Barrett, Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): A case series. Journal of Thrombosis and Haemostasis. ,vol. 18, pp. 1752- 1755 ,(2020) , 10.1111/JTH.14828